Anticoagulation for Patients With Concomitant Atrial Fibrillation and End‐Stage Renal Disease: A Systematic Review and Network Meta‐Analysis
Background Concomitant atrial fibrillation and end‐stage renal disease is common and associated with an unfavorable prognosis. Although oral anticoagulants have been well established to prevent thromboembolism, the applicability in patients under long‐term dialysis remains debatable. The study aimed...
Saved in:
| Main Authors: | Ting‐Wei Kao, Zheng‐Wei Chen, Yen‐Hung Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-04-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.034176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulation Strategies for Atrial Fibrillation in CKD Stage G5 and Dialysis Patients: An Updated Scoping Review
by: Heitor Martins de Oliveira, et al.
Published: (2025-03-01) -
New aspects of anticoagulant therapy in atrial fibrillation in patients with renal dysfunction
by: Zh. D. Kobalava, et al.
Published: (2020-12-01) -
Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
by: B. Rayner
Published: (2012-10-01) -
Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation
by: Ya-Tong Zhang, et al.
Published: (2025-04-01) -
Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)